zanubrutinib,acalabrutinib
astrazeneca,beigene
['zanubrutinib', 'acalabrutinib', 'cll', 'emergent ']
#eha2023 #cll comparison of treatment emergent adverse events of acalabrutinib and zanubrutinib in clinical trials p632
- acala: infections, af, diarrea, gi, headaches, cough, fatigue - zanu: celulitis, hematuria, neutropenia, hypertension 
Este es el Twitter del Grupo Español de Leucemia Linfocítica Crónica